Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CD08514 versus placebo in erythematotelangiectatic rosacea
2009-013111-35Phase 2Completed
- Sponsor
- Galderma
- Start
- Oct 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of V116517 in rosacea (3 arms), sponsored by Galderma. Started Oct 2009; status: completed.
02
Drugs
V116517
03
Conditions
rosacea
Beyond the preview
Go deeper on 2009-013111-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013111-35.